News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Biolex Therapeutics Announces Agreement With Genmab, Inc. (GNMSF.PK) for New Class of Antibodies


5/7/2007 10:50:40 AM

PITTSBORO, NC -- (MARKET WIRE) -- May 07, 2007 -- Biolex Therapeutics today announced an agreement with Genmab A/S, a leading antibody development company. Under the agreement Genmab will evaluate Biolex's patented LEX System(SM) as a potential manufacturing platform for antibodies developed with UniBody™, Genmab's proprietary new antibody technology.

Read at BioSpace.com


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES